BEIJING - Fresh after acquiring U.S. biologics firm AppTec Laboratory Services, WuXi PharmaTech is pushing to rapidly broaden its scope of operations and widen its customer base worldwide, according to WuXi CEO Li Ge
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Sun’s founder hands top job to company longtimer Kirti Ganorkar as the firm implements a “structured and forward-looking” succession plan, while Richard Ascroft will lead the Indian drugmaker’s North America business.
The Belgian drugmaker is boosting its biologics capacity over the pond.
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.
